trending Market Intelligence /marketintelligence/en/news-insights/trending/Utv5ukTDszclEvqoHyR1Qw2 content esgSubNav
In This List

Acucela secures option to buy retinal technology

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity

Blog

Insight Weekly: Bank mergers of equals return; energy tops S&P 500; green bond sales to rise


Acucela secures option to buy retinal technology

Acucela Inc. secured an exclusive option to acquire EyeMedics LLC's proprietary retinal technology for the treatment of certain eye diseases.

While terms of the agreement were not disclosed, Acucela, a Kubota Pharmaceutical Holdings Co. Ltd. subsidiary, noted that the option was acquired under a research and development agreement with the company.